CYB5R2 and cancer: We found, using PCR assays, that the overexpression of CYB5R2, a potential TSG, affected the transcription of genes involved in several major cancer-related pathways, including apoptosis, cell cycle, cell adhesion, angiogenesis, and tumor invasion and metastasis.